Imprimatur Capital

Total investments

7

Average round size

1M

Portfolio companies

6

Rounds per year

0.39

Lead investments

1

Follow on index

0.14

Exits

1

Stages of investment
SeedEarly Stage Venture
Areas of investment
Software Development ApplicationsBiotechnologySoftwareInformation TechnologyHealth DiagnosticsMedical DevicePharmaceuticalTherapeuticsDatabaseClinical Trials

Summary

Imprimatur Capital Ltd appeared to be the VC, which was created in 2002. The venture was found in Europe in United Kingdom. The leading representative office of defined VC is situated in the London.

The overall number of key employees were 2.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Imprimatur Capital Ltd, startups are often financed by Scottish Investment Bank. The meaningful sponsors for the fund in investment in the same round are Xeraya Capital. In the next rounds fund is usually obtained by The North West Fund, Imprimatur Capital Fund Management, BaltCap.

The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Imprimatur Capital Ltd performs on 15 percentage points less the average number of lead investments. The top activity for fund was in 2006. The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. The higher amount of exits for fund were in 2015.

We can highlight the next thriving fund investment areas, such as Biotechnology, Machine Learning. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Evgen Pharma, BigDNA, Boston Neurosciences Inc. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Show more

Investments analytics

Analytics

Total investments
7
Lead investments
1
Exits
1
Rounds per year
0.39
Follow on index
0.14
Investments by industry
  • Health Diagnostics (2)
  • Clinical Trials (2)
  • Medical Device (2)
  • Biotechnology (2)
  • Pharmaceutical (2)
  • Show 13 more
Investments by region
  • United States (2)
  • United Kingdom (4)
  • Uganda (1)
Peak activity year
2006

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Group Appearance index
0.14

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Hertzian 01 Jun 2016 Software, Analytics, Artificial Intelligence, Machine Learning, Big Data, Natural Language Processing Seed Cornwall, Truro, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.